Loading…
Avalo Therapeutics, Inc. is projected to rise to $28.51 by 2027, a +48% move from its current price of $19.21. AVTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $18.39 | $19.22 | $20.08 | +0.04% |
| Jul 13 | $18.06 | $19.23 | $20.46 | +0.09% |
| Jul 14 | $17.82 | $19.24 | $20.76 | +0.13% |
| Jul 15 | $17.62 | $19.24 | $21.02 | +0.17% |
| Jul 16 | $17.44 | $19.25 | $21.25 | +0.22% |
| Jul 17 | $17.29 | $19.26 | $21.46 | +0.26% |
| Jul 18 | $17.15 | $19.27 | $21.65 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.15 | $19.27 | $21.65 | +0.31% |
| Week 2 | $16.39 | $19.33 | $22.79 | +0.61% |
| Week 3 | $15.84 | $19.39 | $23.73 | +0.92% |
| Week 4 | $15.40 | $19.45 | $24.55 | +1.23% |
| Week 5 | $15.03 | $19.50 | $25.32 | +1.54% |
| Week 6 | $14.70 | $19.56 | $26.03 | +1.85% |
| Week 7 | $14.41 | $19.62 | $26.72 | +2.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases.
The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania. It is categorized in Healthcare.
Avalo Therapeutics, Inc. (AVTX) is currently priced at $18.84 with a market capitalization of $990.34M. It ranks 2506.
The stock is categorized in Healthcare. The forecast suggests a bullish price outlook over the longer term, with 2026 showing a neutral stance and 2027 onward expected bullish momentum. In 2026 the min is $12.74, avg is $18.84, max is $30.09, with ROI 0 and sentiment NEUTRAL.
From 2027 onward the forecast shows rising averages and upside, culminating in a 2050 avg of $253.44 and a max of $582.90, supported by bullish sentiment across 2027-2050.
A major floor 47.5% below — a decisive break under it would weaken the trend.
The nearest floor, 33.7% below — buyers have tended to step in here.
The nearest ceiling, 3.9% above — a clean break opens room to run.
A major ceiling 27.7% above — clearing it would confirm fresh momentum.
Key AVTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AVTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.52 | Sell | $19.30 | Sell |
| MA 10 | $18.97 | Buy | $18.81 | Buy |
| MA 20 | $17.41 | Buy | $17.87 | Buy |
| MA 50 | $16.72 | Buy | $16.78 | Buy |
| MA 100 | $16.02 | Buy | $16.20 | Buy |
| MA 200 | $16.09 | Buy | $15.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.22 | Neutral |
| Stoch RSI (14) | 30.48 | Neutral |
| CCI (20) | 68.73 | Neutral |
| Williams %R (14) | -26.04 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 7.74 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 73.96 | Neutral |
| TRIX (15) | 0.76 | Buy |
| Awesome (5,34) | 3.22 | Buy |
| Ultimate (7,14,28) | 60.09 | Neutral |
| Momentum (10) | 1.21 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 19.77 | Sell |
| ADX (14) | 21.47 | Buy |
| ATR (14) | 0.73 | Info |
30-day technical picture:
- Sentiment: BULLISH
- RSI(14): 60
- SMA50: $16.18
- SMA200: $15.89
- 30-day range: $13.75 to $25.81
- Support: $12.74
- Resistance: $19.29
Annualized volatility: 90%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.74 | $19.21 | $29.45 | 0% | Neutral | |
| $21.40 | $28.51 | $40.85 | +48% | Bullish | |
| $27.15 | $37.95 | $57.44 | +98% | Bullish | |
| $26.74 | $38.94 | $61.48 | +103% | Bullish | |
| $27.85 | $42.07 | $68.79 | +119% | Bullish | |
| $27.27 | $42.61 | $71.83 | +122% | Bullish | |
| $25.23 | $40.70 | $70.48 | +112% | Bullish | |
| $31.54 | $52.45 | $93.07 | +173% | Bullish | |
| $38.91 | $66.64 | $120.88 | +247% | Bullish | |
| $41.02 | $72.28 | $133.82 | +276% | Bullish | |
| $46.40 | $93.55 | $188.48 | +387% | Bullish | |
| $86.53 | $192.28 | $436.74 | +901% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $12.74 | $19.21 | $24.32 | +0.00% |
| August 2026 | $17.03 | $20.44 | $25.44 | +6.39% |
| September 2026 | $16.46 | $19.99 | $25.31 | -2.20% |
| October 2026 | $17.17 | $21.06 | $27.06 | +5.35% |
| November 2026 | $18.29 | $22.62 | $29.42 | +7.43% |
| December 2026 | $17.97 | $22.39 | $29.45 | -1.01% |
Click any year to see its month-by-month AVTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AVTX to range from $12.74 to $29.45 through 2026. The $19.21 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AVTX price prediction for 2027 points to an average of $28.51 (low $21.40, high $40.85) — a potential gain of +48% on today's $19.21. Buyers look set to stay in control over this stretch.
In 2028, AVTX is projected to trade between $27.15 and $57.44, averaging $37.95 — a potential gain of +98% from today's $19.21. That is up +33% on the projected 2027 average. Momentum favours further upside here.
Avalo Therapeutics, Inc.'s 2029 outlook centres on $38.94, within a $26.74 to $61.48 range. That is up +3% on the projected 2028 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AVTX could reach as high as $68.79, with a base case around $42.07 and support toward $27.85 — roughly +119% from $19.21. Momentum favours further upside here.
Expect AVTX to range from $27.27 to $71.83 through 2031. The $42.61 average target implies a +122% move from current prices. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AVTX price prediction for 2032 points to an average of $40.70 (low $25.23, high $70.48) — a potential gain of +112% on today's $19.21. Momentum favours further upside here.
In 2033, AVTX is projected to trade between $31.54 and $93.07, averaging $52.45 — a potential gain of +173% from today's $19.21. That is up +29% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Avalo Therapeutics, Inc.'s 2034 outlook centres on $66.64, within a $38.91 to $120.88 range. That is up +27% on the projected 2033 average. That marks a +247% change versus current levels. Momentum favours further upside here.
By 2035, AVTX could reach as high as $133.82, with a base case around $72.28 and support toward $41.02 — roughly +276% from $19.21. Buyers look set to stay in control over this stretch.
Expect AVTX to range from $46.40 to $188.48 through 2040. The $93.55 average target implies a +387% move from current prices. That is up +29% on the projected 2035 average. Momentum favours further upside here.
The AVTX price prediction for 2050 points to an average of $192.28 (low $86.53, high $436.74) — a potential gain of +901% on today's $19.21. Buyers look set to stay in control over this stretch.
Investing $1,000 in AVTX today (≈ 52.056221 AVTX) could be worth
$10,009.33
+$9,009.33 (+901%) by 2050 · US Dollar
Based on the average projected AVTX price of $192.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AVTXwould be worth at today's price.
$1,000 invested in AVTX on Jul 10, 2025 (≈ 204.081629 AVTX) would be worth
$3,920.41
+$2,920.41 (+292.0%) today · 3.92× · US Dollar
Based on a AVTX entry price of $4.9 vs. today's $19.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.84 | $1,019.64 | +2.0% |
| 1 month ago | $13.1 | $1,466.41 | +46.6% |
| 3 months ago | $13.66 | $1,406.3 | +40.6% |
| 6 months ago | $16.67 | $1,152.37 | +15.2% |
| 1 year ago | $4.9 | $3,920.41 | +292.0% |
| All time (5.0y) ago | $9,302.4 | $2.07 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AVTX forecast.
Our base-case forecast reaches $38.00 around 2029.
Implied market cap at $38.00: $2B
Multi-year forecast shows a bullish trajectory with rising averages and substantial upside across the horizon. The 2027 forecast starts with an avg of $30.84, followed by strong gains to an avg of $47.35 in 2030 and then to $124.63 by 2040, ending at an avg of $253.44 in 2050. The corresponding ROIs rise from 63.7% in 2027 to 151.3% in 2030, then 561.5% in 2040 and 1,245.2% in 2050, with sentiment remaining BULLISH after 2026.
In this long‑range view, the asset exhibits bullish sentiment through 2030 and beyond, with the max values climbing to as high as $582.90 in 2050. These figures are estimates, not guarantees, and actual results can vary due to market and other risks.
Tap a question to reveal the answer.
2026 min $12.74, avg $18.84, max $30.09; ROI 0%; sentiment NEUTRAL.
The forecast shows bullish sentiment from 2027 onward, with avg prices rising to $30.84 in 2027, $47.35 by 2030, and $253.44 by 2050; ROI up to 1245.2%. The 2026 view is neutral.
Yes. The forecast max reaches $119.00 in 2033 and $155.59 in 2034, with higher peaks later, indicating potential to exceed $100.
Avg $47.35; min $30.50; max $79.38; ROI 151.3%; sentiment BULLISH.
Min $114.05; Avg $253.44; Max $582.90; ROI 1245.2%; sentiment BULLISH.
Avalo Therapeutics, Inc. Community Discussion
0Share your Avalo Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.